Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2019
Women's cancer fight reaches Parliament and Health select committee
13 March 2019 - Six months after presenting petitions to Parliament calling for better access to life-prolonging medicine, Sue Wall-Cade ...
Posted by Michael Wonder on 10 Mar 2019
Family of sick toddler launches petition urging PHARMAC to fund life-extending drug Spinraza
10 March 2019 - A Pukekohe family has launched a petition urging PHARMAC to fund a drug for spinal muscular ...
Posted by Michael Wonder on 08 Mar 2019
Decision to make changes to funded haemophilia treatments
8 March 2019 - PHARMAC is pleased to announce changes to funded haemophilia treatments that will result in two new ...
Posted by Michael Wonder on 07 Mar 2019
Prioritise lung cancer treatments, patients tell MPs
7 March 2019 - Lung cancer patients are launching a petition for MPs to back more treatments at a drug funding ...
Posted by Michael Wonder on 28 Feb 2019
New Zealand Pharmaceutical Schedule - 1 March 2019 update
1 March 2019 - The March 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Feb 2019
Kiwi women fighting for early ovarian cancer diagnosis and access to drugs
28 February 2019 - Sue Duncan,56, a midwife who lives in Cambridge, was diagnosed with ovarian cancer in January 2017. She ...
Posted by Michael Wonder on 27 Feb 2019
'Depriving sick babies of right to life' - NZORD boss blasts PHARMAC decision to defer Spinraza
28 February 2019 - Clinical experts deciding whether to fund a drug that would prolong the life of babies with ...
Posted by Michael Wonder on 18 Feb 2019
Medicines for rare disorders
13 February 2019 - PHARMAC is working on policy and funding for medicines for rare disorders. ...
Posted by Michael Wonder on 18 Feb 2019
Decision on spinal muscular atrophy treatment Spinraza deferred
18 February 2019 - PHARMAC's decision to defer a decision on funding the only treatment for spinal muscular atrophy (SMA) ...
Posted by Michael Wonder on 14 Feb 2019
OIA responses: exploring ways to publish them
14 February 2019 - To support New Zealand's commitment to open government, PHARMAC is exploring ways to publish more of ...
Posted by Michael Wonder on 13 Feb 2019
PHARMAC to review its practices following criticism of breast cancer drug funding
13 February 2019 - The government's drug-buying agency has announced it has begun an internal review following a petition and ...
Posted by Michael Wonder on 12 Feb 2019
Breast cancer patients die while waiting for medicines
12 February 2019 - Women with terminal breast cancer will be sharing their heartfelt stories with MPs about the dire ...
Posted by Michael Wonder on 08 Feb 2019
Wellbeing budget total nonsense when too many are dying early
9 November 2019 - Five women who marched on Parliament last year for access to the best cancer drugs on ...
Posted by Michael Wonder on 08 Feb 2019
When cancer is political
8 February 2019 - Should cancer be politicised? And, should the debate about it be personalised, with a focus on ...
Posted by Michael Wonder on 06 Feb 2019
Comparing PHARMAC's outcomes with those of Australia
7 February 2019 - New Zealand's Prime Minister Jacinda Ahern's claim that is unfair to compare PHARMAC's outcomes with those ...